(Q33687976)

28 July 2017

1 reference

title

The human immune response during cutaneous leishmaniasis: NO problem (English)

1 reference

28 July 2017

main subject

cutaneous leishmaniasis

1 reference

Mossalayi MD

1

1 reference

28 July 2017

Arock M

2

1 reference

28 July 2017

Mazier D

3

1 reference

28 July 2017

Vincendeau P

4

1 reference

28 July 2017

Vouldoukis I

5

1 reference

28 July 2017

publication date

1 August 1999

1 reference

28 July 2017

published in

Trends in Parasitology

1 reference

28 July 2017

volume

15

1 reference

28 July 2017

issue

8

1 reference

28 July 2017

page(s)

342-345

1 reference

Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

The regulation of immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Type 2 cytokines and negative immune regulation in human infections

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Invasion, control and persistence of Leishmania parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Tumor necrosis factor (cachectin) in human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Human monocytes/macrophages: NO or no NO?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Early IL-4 production does not predict susceptibility to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: possible role in monocyte activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

CD23/Fc epsilon RII: signaling and clinical implication

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Nitric oxide production by human monocytes: evidence for a role of CD23.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Cytokine patterns in the pathogenesis of human leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Inflammation, immunoregulation, and inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

The L-arginine-nitric oxide pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

Treatment of cutaneous leishmaniasis with nitric-oxide donor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2899%2901477-5

7 January 2021

10.1016/S0169-4758(99)01477-5

Identifiers

DOI

1 reference

28 July 2017

1 reference